The development seen for VAXINIA is considered late stage of Ph2 clinical trial and the same will be for OASIS provided there are efficacy seen early in Ph1 clinical trial similar to VAXINIA. There's a registrational clinical trial path for Azer-Cel so it is consider the end of Ph2 clinical trial now with registrational clinical trial the start of Ph3 clinical trial.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $179.4K | 14.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 15731879 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3463196 | 20 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |